Federal Register / Vol. 87, No. 101 / Wednesday, May 25, 2022 / Notices 31907 

Controlled substance Drug code Schedule 

Ethylmorphine ........................................................................................................................................................................ 9190 II 

Levomethorphan .................................................................................................................................................................... 9210 II 

Levorphanol ........................................................................................................................................................................... 9220 II 

Isomethadone ........................................................................................................................................................................ 9226 II 

Meperidine ............................................................................................................................................................................. 9230 II 

Meperidine intermediate-A .................................................................................................................................................... 9232 II 

Meperidine intermediate-B .................................................................................................................................................... 9233 II 

Meperidine intermediate-C .................................................................................................................................................... 9234 II 

Metazocine ............................................................................................................................................................................ 9240 II 

Oliceridine (N-[(3-methoxythiophen-2yl)methyl] ({2-[9r)-9-(pyridin-2-yl)-6-oxaspiro[4.5] decan-9-yl] ethyl {time})amine fumarate).9245 II 

Metopon ................................................................................................................................................................................. 9260 II 

Dextropropoxyphene, bulk (non-dosage forms) .................................................................................................................... 9273 II 

Dihydroetorphine ................................................................................................................................................................... 9334 II 

Opium tincture ....................................................................................................................................................................... 9630 II 

Opium, powdered .................................................................................................................................................................. 9639 II 

Opium, granulated ................................................................................................................................................................. 9640 II 

Noroxymorphone ................................................................................................................................................................... 9668 II 

Phenazocine .......................................................................................................................................................................... 9715 II 

Thiafentanil ............................................................................................................................................................................ 9729 II 

Piminodine ............................................................................................................................................................................. 9730 II 

Racemethorphan ................................................................................................................................................................... 9732 II 

Racemorphan ........................................................................................................................................................................ 9733 II 

Alfentanil ................................................................................................................................................................................ 9737 II 

Remifentanil ........................................................................................................................................................................... 9739 II 

Sufentanil ............................................................................................................................................................................... 9740 II 

Carfentanil ............................................................................................................................................................................. 9743 II 

Tapentadol ............................................................................................................................................................................. 9780 II 

Bezitramide ............................................................................................................................................................................ 9800 II 

Moramide-intermediate .......................................................................................................................................................... 9802 II 

The company plans to import small 

quantities of the listed controlled 

substances for the National Institute on 

Drug Abuse for research activities. The 

company plans to import analytical 

reference standards for distribution to 

its customers for research and analytical 

purposes. No other activity for this drug 

code is authorized for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Kristi N. O’Malley, 

Assistant Administrator. 

[FR Doc. 2022–11259 Filed 5–24–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1019] 

Importer of Controlled Substances 

Application: Johnson Matthey Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Johnson Matthey Inc. has 

applied to be registered as an importer 

of basic class(es) of controlled 

substance(s). Refer to SUPPLEMENTARY

INFORMATION listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before June 24, 2022. Such persons 

may also file a written request for a 

hearing on the application on or before 

June 24, 2022. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on November 2, 2020, 

Johnson Matthey Inc., 2003 Nolte Drive, 

West Deptford, New Jersey 08066–1742, 

applied to be registered as an importer 

of the following basic class(es) of 

controlled substance(s): 

Controlled substance Drug 

code Schedule 

Coca Leaves ............................. 9040 II 

Thebaine ................................... 9333 II 

Opium, raw ............................... 9600 II 

Noroxymorphone ...................... 9668 II 

Poppy Straw Concentrate ......... 9670 II 

Fentanyl .................................... 9801 II 

The company plans to import Coca 

Leaves (9040), Opium, raw (9600), and 

Poppy Straw Concentrate (9670) in 

order to bulk manufacture Active 

Pharmaceutical Ingredients (API) for 

distribution to its customers. The 

company plans to also import Thebaine 

(9333), Noroxymorphone (9668), and 


lotter on DSK11XQN23PROD with NOTICES1
31908 Federal Register / Vol. 87, No. 101 / Wednesday, May 25, 2022 / Notices 

Fentanyl (9801) to use as analytical 

reference standards, both internally and 

to be sold to their customers to support 

testing of Johnson Matthey Inc.’s API’s 

only. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Kristi N. O’Malley, 

Assistant Administrator. 

[FR Doc. 2022–11267 Filed 5–24–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1013] 

Importer of Controlled Substances 

Application: Wildlife Laboratories, LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Wildlife Laboratories, LLC 

has applied to be registered as an 

importer of basic class(es) of controlled 

substance(s). Refer to SUPPLEMENTARY

INFORMATION listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before June 24, 2022. Such 

persons may also file a written request 

for a hearing on the application on or 

before June 24, 2022. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on April 6, 2022, Wildlife 

Laboratories, LLC, 1230 West Ash 

Street, Unit D, Windsor, Colorado 

80550–4677, applied to be registered as 

an importer of the following basic 

class(es) of controlled substance(s): 

Controlled 

substance 

Drug 

code Schedule 

Etorphine HCL ................. 9059 II 

Thiafentanil ...................... 9729 II 

The company plans to import the 

listed controlled substances for 

distribution to its customers. No other 

activity for these drug codes is 

authorized for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Kristi N. O’Malley, 

Assistant Administrator. 

[FR Doc. 2022–11260 Filed 5–24–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1018] 

Importer of Controlled Substances 

Application: Catalent Pharma 

Solutions, LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: VHG Labs DBA LGC 

Standards has applied to be registered 

as an importer of basic class(es) of 

controlled substance(s). Refer to 

SUPPLEMENTARY INFORMATION listed 

below for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before June 24, 2022. Such 

persons may also file a written request 

for a hearing on the application on or 

before June 24, 2022. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on March 17, 2022, 

Catalent Pharma Solutions, LLC, 3031 

Red Lion Road, Philadelphia, 

Pennsylvania 19114, applied to be 

registered as an importer of the 

following basic class(es) of controlled 

substance(s): 

Controlled 

substance 

Drug 

code Schedule 

5-Methoxy-N-Ndimethyltryptamine.7431 I 

Tapentadol ...................... 9780 II 

The company plans to import the 

listed controlled substances as finished 

dosage unit products for clinical trials, 

research, and analytical activities. No 

other activities for these drug codes are 

authorized for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonVerDate Sep<11>2014 17:43 May 24, 2022 Jkt 256001 PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 E:\FR\FM\25MYN1.SGM 25MYN1

lotter on DSK11XQN23PROD with NOTICES1

I I 

I I